Hims & Hers Health Other Current Assets 2020-2025 | HIMS

Hims & Hers Health other current assets from 2020 to 2025. Other current assets can be defined as field containing the sum of all current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
  • Hims & Hers Health other current assets for the quarter ending March 31, 2025 were $0M, a 0% increase year-over-year.
  • Hims & Hers Health other current assets for 2024 were $0B, a 0% decline from 2023.
  • Hims & Hers Health other current assets for 2023 were $0B, a 0% decline from 2022.
  • Hims & Hers Health other current assets for 2022 were $0B, a 0% decline from 2021.
Hims & Hers Health Annual Other Current Assets
(Millions of US $)
2024 $0
2023 $0
2022 $0
2021 $0
2020 $0
2019 $0
2018 $0
Hims & Hers Health Quarterly Other Current Assets
(Millions of US $)
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31
2019-12-31
2019-09-30
2019-06-30
Sector Industry Market Cap Revenue
Medical Medical Information Systems $13.954B $1.477B
Hims & Hers Health Inc. is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling medical care for numerous conditions related to mental health, sexual health, dermatology, primary care and more. Hims & Hers Health Inc., formerly known as Oaktree Acquisition Corp., is based in San Francisco.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $38.988B 53.85
Tempus AI (TEM) United States $10.977B 0.00
IRhythm Technologies (IRTC) United States $4.526B 0.00
Inspire Medical Systems (INSP) United States $4.418B 69.02
Privia Health (PRVA) United States $3.048B 208.33
Enovis (ENOV) United States $2.027B 11.30
Clover Health Investments (CLOV) United States $1.832B 0.00
Schrodinger (SDGR) United States $1.721B 0.00
Phreesia (PHR) United States $1.510B 0.00
Omnicell (OMCL) United States $1.305B 23.02
Azenta (AZTA) United States $1.242B 57.70
10x Genomics (TXG) United States $1.100B 0.00
Fulgent Genetics (FLGT) United States $0.646B 0.00
Butterfly Network (BFLY) United States $0.574B 0.00
Talkspace (TALK) United States $0.504B 150.50
Veradigm (MDRX) United States $0.476B 0.00
Claritev (CTEV) United States $0.452B 0.00
Standard BioTools (LAB) United States $0.399B 0.00
TruBridge (TBRG) United States $0.376B 834.00
Health Catalyst (HCAT) United States $0.271B 0.00
Nyxoah SA (NYXH) Belgium $0.231B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.191B 0.00
EUDA Health Holdings (EUDA) Singapore $0.144B 0.00
Pulmonx (LUNG) United States $0.134B 0.00
American Well (AMWL) United States $0.114B 0.00
MDxHealth SA (MDXH) Belgium $0.098B 0.00
CareCloud (CCLD) United States $0.088B 3.34
Outset Medical (OM) United States $0.070B 0.00
111 (YI) China $0.068B 0.00
Retrieve Medical Holdings (RMHI) United States $0.059B 0.00
P3 Health Partners (PIII) United States $0.057B 0.00
HeartBeam (BEAT) United States $0.055B 0.00
Zepp Health (ZEPP) Netherlands $0.041B 0.00
Zhongchao (ZCMD) China $0.032B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.022B 0.00
Bullfrog AI Holdings (BFRG) United States $0.016B 0.00
MSP Recovery (MSPR) United States $0.013B 0.00
Precipio (PRPO) United States $0.013B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Streamline Health Solutions (STRM) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.009B 0.00
Movano (MOVE) United States $0.006B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Healthcare Triangle (HCTI) United States $0.000B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00